Perennial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.34M | Sell |
17,507
-2,212
| -11% | -$757K | 0.98% | 31 |
|
|
2026
Q1 | $6.94M | Sell |
19,719
-237
| -1% | -$84.5K | 1.18% | 29 |
|
|
2025
Q4 | $6.53M | Buy |
19,956
+579
| +3% | +$184K | 1.1% | 31 |
|
|
2025
Q3 | $5.47M | Sell |
19,377
-1
| -0% | -$290 | 0.95% | 36 |
|
|
2025
Q2 | $5.41M | Sell |
19,378
-293
| -1% | -$83K | 1.01% | 33 |
|
|
2025
Q1 | $6.13M | Buy |
19,671
+530
| +3% | +$157K | 1.22% | 30 |
|
|
2024
Q4 | $4.99M | Buy |
+19,141
| New | +$5.68M | 1.09% | 32 |
|
|
2024
Q2 | $5.73M | Buy |
18,323
+171
| +0.9% | +$50.2K | 1.28% | 28 |
|
|
2024
Q1 | $5.16M | Sell |
18,152
-196
| -1% | -$57.4K | 1.2% | 30 |
|
|
2023
Q4 | $5.28M | Buy |
18,348
+196
| +1% | +$53.4K | 1.3% | 30 |
|
|
2023
Q3 | $4.88M | Buy |
18,152
+128
| +0.7% | +$31.9K | 1.32% | 30 |
|
|
2023
Q2 | $4M | Buy |
18,024
+598
| +3% | +$139K | 1.02% | 38 |
|
|
2023
Q1 | $4.21M | Buy |
17,426
+310
| +2% | +$76.1K | 1.21% | 34 |
|
|
2022
Q4 | $4.5M | Sell |
17,116
-618
| -3% | -$166K | 1.43% | 32 |
|
|
2022
Q3 | $4M | Buy |
17,734
+62
| +0.4% | +$15K | 1.31% | 35 |
|
|
2022
Q2 | $4.3M | Buy |
17,672
+198
| +1% | +$48.5K | 1.34% | 35 |
|
|
2022
Q1 | $4.23M | Sell |
17,474
-1,686
| -9% | -$387K | 1.12% | 36 |
|
|
2021
Q4 | $4.31M | Sell |
19,160
-1,212
| -6% | -$256K | 1.16% | 36 |
|
|
2021
Q3 | $4.33M | Buy |
20,372
+960
| +5% | +$221K | 1.28% | 36 |
|
|
2021
Q2 | $4.73M | Buy |
19,412
+238
| +1% | +$58.5K | 1.37% | 36 |
|
|
2021
Q1 | $4.77M | Buy |
19,174
+208
| +1% | +$49.6K | 1.5% | 32 |
|
|
2020
Q4 | $4.36M | Buy |
18,966
+487
| +3% | +$112K | 1.54% | 33 |
|
|
2020
Q3 | $4.7M | Buy |
18,479
+106
| +0.6% | +$26.3K | 1.92% | 23 |
|
|
2020
Q2 | $4.33M | Buy |
18,373
+450
| +3% | +$103K | 1.84% | 22 |
|
|
2020
Q1 | $3.63M | Buy |
17,923
+1,425
| +9% | +$311K | 2.02% | 19 |
|
|
2019
Q4 | $3.98M | Buy |
16,498
+69
| +0.4% | +$15.2K | 1.91% | 23 |
|
|
2019
Q3 | $3.18M | Buy |
16,429
+515
| +3% | +$98.9K | 1.65% | 30 |
|
|
2019
Q2 | $2.93M | Buy |
15,914
+997
| +7% | +$179K | 1.56% | 31 |
|
|
2019
Q1 | $2.83M | Buy |
14,917
+420
| +3% | +$80.2K | 1.61% | 30 |
|
|
2018
Q4 | $2.82M | Buy |
14,497
+479
| +3% | +$93.4K | 1.83% | 22 |
|
|
2018
Q3 | $2.91M | Sell |
14,018
-21
| -0.1% | -$4.14K | 1.67% | 25 |
|
|
2018
Q2 | $2.59M | Buy |
14,039
+543
| +4% | +$96K | 1.6% | 26 |
|
|
2018
Q1 | $2.3M | Sell |
13,496
-365
| -3% | -$67K | 1.45% | 31 |
|
|
2017
Q4 | $2.41M | Buy |
13,861
+133
| +1% | +$23.5K | 1.5% | 32 |
|
|
2017
Q3 | $2.56M | Buy |
13,728
+319
| +2% | +$56.5K | 1.73% | 24 |
|
|
2017
Q2 | $2.31M | Buy |
13,409
+480
| +4% | +$78.1K | 1.68% | 25 |
|
|
2017
Q1 | $2.12M | Buy |
12,929
+1,138
| +10% | +$189K | 1.63% | 28 |
|
|
2016
Q4 | $1.72M | Buy |
+11,791
| New | +$1.77M | 1.43% | 29 |
|
Other funds holding AMGN
FFM
SP
Perennial Advisors's AMGN Position: Q2 2026 in Review
Perennial Advisors reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $757K and leaving 17,507 shares worth $6.34M. The position accounts for 0.98% of the portfolio, ranked #31.
Perennial Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $6.94M in Q1 2026. 1,289 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Perennial Advisors held 17,507 shares of Amgen worth $6.34M as of Q2 2026.
- Perennial Advisors sold 2,212 Amgen shares in Q2 2026, an estimated $757K.
- Amgen made up 0.98% of Perennial Advisors's portfolio in Q2 2026, its #31 holding.
- Perennial Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- Perennial Advisors's Amgen position peaked at $6.94M in Q1 2026.
- 1,289 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Perennial Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.